Publications by authors named "Facheng Ma"
Article Synopsis
- - The main treatments for hyperuricemia and gout are xanthine oxidase (XO) inhibitors and urate transporter 1 (URAT1) inhibitors, but these have limitations in effectiveness and safety.
- - Researchers developed a new dual inhibitor that targets both XO and URAT1 to potentially improve treatment outcomes and reduce toxicity.
- - This new compound showed strong inhibition of both targets and favorable safety profiles in animal studies, making it a promising candidate for gout treatment.
View Article and Find Full Text PDF